BioPharma Clinical Trials
Shanghai MicuRx Achieves Key Milestone in Combatting Drug-Resistant Infections with Successful Phase I Trial of MRX-8
According to the World Health Organization (WHO), millions of patients face treatment difficulties or even life-threatening conditions due to resistant b...
June 07, 2024 | News
I-Mab Partners with Bristol Myers Squibb for Phase 1 Clinical Trial of Novel Cancer Therapy
I-Mab , a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapi...
June 06, 2024 | News
Thermo Fisher Scientific Opens Cutting-Edge Ultra-Cold Facility in EU to Boost Advanced Therapy Development
Thermo Fisher Scientific Inc., the world leader in serving science, has opened a new clinical and commercial ultra-cold facility in the EU, expanding its c...
June 03, 2024 | News
AstraZeneca’s TAGRISSO® Shows Significant Improvement in Progression-Free Survival in Phase III LAURA Trial for EGFR-Mutated NSCLC
Positive results from the LAURA Phase III trial showed AstraZeneca’s TAGRISSO® (osimertinib) demonstrated a statistically significant a...
June 03, 2024 | News
EMA CHMP Recommends Approval of Sugemalimab for First-Line Treatment of NSCLC
EMA CHMP recommendation is based on the results of a Phase 3 clinical trial (GEMSTONE-302) demonstrating significant progression-free survival (PFS) and ...
June 03, 2024 | News
Fortrea Launches Comprehensive Solution to Enhance Diversity and Inclusion in Clinical Trials
Fortrea, a leading global contract research organization (CRO), today announced its comprehensive and integrated solution to improve the diversity an...
May 31, 2024 | News
Kexing Biopharm’s Subsidiary Receives Approval for Clinical Trials of Innovative GB08 Growth Hormone
Kexing Biopharm announced that Shenzhen Kexing Pharmaceutical Co., Ltd., its wholly-owned subsidiary, recently received a Notice of Approval for Drug Clini...
May 31, 2024 | News
HanAll Biopharma Secures Exclusive Rights to Cutting-Edge Aging Reprogramming Technology
Exclusive agreement allows HanAll to utilize Epigenetic Reprogramming of Aging (ERATM) technology for ophthalmic and otic diseases. Collaboration aims t...
May 29, 2024 | News
Innovent Biologics Announces Phase 3 Success for Picankibart in Treating Moderate to SevereInnovent Biologics Announces Phase 3 Success for Picankibart in Treating Moderate to Severe Plaque Psoriasis
Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of canc...
May 28, 2024 | News
Neuren Pharmaceuticals Announces Positive Phase 2 Trial Results for NNZ-2591 in Pitt Hopkins Syndrome
Neuren Pharmaceuticals revealed top-line results from its Phase 2 clinical trial of NNZ-2591 in children with Pitt Hopkins syndrome (PTHS). This trial demo...
May 28, 2024 | News
Henlius Biotech and Organon Receive EMA Validation for Denosumab Biosimilar HLX14
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing autho...
May 27, 2024 | News
Tyligand Bioscience Doses First Patient in Phase 1/2 Trial for Innovative KRAS G12D Cancer Therapy
Tyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies, announced that the fir...
May 27, 2024 | News
Telix Pharmaceuticals Submits NDA for Innovative Prostate Cancer Imaging Kit to FDA
Telix Pharmaceuticals announces it has submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA...
May 27, 2024 | News
Laekna Receives FDA Approval for Phase III Trial of Innovative mCRPC Treatment
Laekna, Inc. (2105.HK), a science-driven, clinical-stage biotechnology company, announced that the company has received approval from the U.S. Food an...
May 24, 2024 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
